Chinese police have accused a British executive in drugs maker GlaxoSmithKline's China unit of ordering his salespeople to bribe doctors and hospital officials to use the company's products.
Wednesday's announcement marks the first time a foreign employee in China of British-based GSK has been accused in connection with the bribery allegations against the company.
In a statement carried by the official Xinhua news agency, police in the central city of Changsha said Mark Reilly was accused of pressing his sales team to bribe doctors, hospital officials and health institutions. It said that resulted in "illegal revenue" of billions of yuan.
The statement said Reilly and two Chinese executives also were accused of bribing government officials in Beijing and Shanghai.
In April the GSK whistleblower Jarek Wisniewiski told the BBC's Panorama programme that company representatives paid doctors to boost prescriptions in Poland. Full story...
Related posts:
Wednesday's announcement marks the first time a foreign employee in China of British-based GSK has been accused in connection with the bribery allegations against the company.
In a statement carried by the official Xinhua news agency, police in the central city of Changsha said Mark Reilly was accused of pressing his sales team to bribe doctors, hospital officials and health institutions. It said that resulted in "illegal revenue" of billions of yuan.
The statement said Reilly and two Chinese executives also were accused of bribing government officials in Beijing and Shanghai.
In April the GSK whistleblower Jarek Wisniewiski told the BBC's Panorama programme that company representatives paid doctors to boost prescriptions in Poland. Full story...
Related posts:
- Drugs giant GlaxoSmithKline bribed doctors to boost sales...
- GlaxoSmithKline behaved like a criminal “godfather” in China...
- Drug giant GlaxoSmithKline to pay $3billion in US drug fraud scandal...
- GlaxoSmithKline whistleblower speaks out about bribery of doctors, off-label...
- Big Pharma made $711 billion overcharging seniors and disabled in the US...
- Italy slaps Swiss pharma giants Novartis and Roche with huge fines...
- French pharmaceutical giant Sanofi in China bribes allegation...
No comments:
Post a Comment